Middle cerebral artery remodeling following transient brain ischemia is linked to early postischemic hyperemia: A target of uric acid treatment

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 308, Issue 8, 2015, Pages H862-H874

  Onetti, Yara ^a   Dantas, Ana P ^b   Pérez, Belén ^a   Cugota, Roger ^a   Chamorro, Angel ^c   Planas, Anna M ^b   Vila, Elisabet ^a   Jiménez Altayó, Francesc ^a  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Interleukin 18; Ischemia reperfusion; Macrophages; Oxidative stress; Peroxynitrite

Indexed keywords

INTERLEUKIN 18; URIC ACID; ANTIOXIDANT;

ADULT; ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN DAMAGE; BRAIN INFARCTION; BRAIN PERFUSION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; HYPEREMIA; INFLAMMATION; INJURY SEVERITY; MALE; MIDDLE CEREBRAL ARTERY; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRANSIENT ISCHEMIC ATTACK; ANIMAL; GENETICS; INFARCTION, MIDDLE CEREBRAL ARTERY; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; HYPEREMIA; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-18; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; URIC ACID;

EID: 84927944493     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00001.2015     Document Type: Article

References (39)

1. Amaro S, Planas AM, Chamorro A. Uric acid administration in patients with acute stroke: a novel approach to neuroprotection. Expert Rev Neurother 8: 259-270, 2008.
2. Arribas SM, Hillier C, González C, McGrory S, Dominiczak AF, McGrath JC. Cellular aspects of vascular remodeling in hypertension revealed by confocal microscopy. Hypertension 30: 1455-1464, 1997.
3. Baumbach GL, Didion SP, Faraci FM. Hypertrophy of cerebral arterioles in mice deficient in expression of the gene for CuZn superoxide dismutase. Stroke 37: 1850-1855, 2006.
4. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624, 1990.
5. Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Martí- Fábregas, J, Gállego J, Krupinski J, Gomis M, Cánovas D, Carné X, Deulofeu R, Román LS, Oleaga L, Torres F, Planas AM; Investigators URICOICTUS. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial. Lancet Neurol 13: 453-460, 2014.
6. Cipolla MJ, Lessov N, Hammer ES, Curry AB. Threshold duration of ischemia for myogenic tone in middle cerebral arteries: effect on vascular smooth muscle actin. Stroke 32: 1658-1664, 2001.
7. Cipolla MJ, McCall AL, Lessov N, Porter JM. Reperfusion decreases myogenic reactivity and alters middle cerebral artery function after focal cerebral ischemia in rats. Stroke 28: 176-180, 1997.
8. Coucha M, Li W, Johnson MH, Fagan SC, Ergul A. Protein nitration impairs the myogenic tone of rat middle cerebral arteries in both ischemic and nonischemic hemispheres after ischemic stroke. Am J Physiol Heart Circ Physiol 305: H1726-H1735, 2013.
9. Di L, Kerns EH, Fan K, McConnell OJ, Carter GT. High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem 38: 223-232, 2003.
10. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 66: 8-17, 1990.
11. Green LC, Wagner DA, Glogowski J, Skiper PL, Wishnock JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal Biochem 126: 131-138, 1982.
12. Humphreys SA, Koss MC. Role of nitric oxide in post-ischemic cerebral hyperemia in anesthetized rats. Eur J Pharmacol 347: 223-229, 1998.
13. Jiang Z, Li C, Arrick DM, Yang S, Baluna AE, Sun H. Role of nitric oxide synthases in early blood-brain barrier disruption following transient focal cerebral ischemia. PLoS One 9: e93134, 2014.
14. Jiménez-Altayó F, Caracuel L, Pérez-Asensio FJ, Martínez-Revelles S, Messeguer A, Planas AM, Vila E. Participation of oxidative stress on rat middle cerebral artery changes induced by focal cerebral ischemia: beneficial effects of 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl- 1(2H)-benzopyran (CR-6). J Pharmacol Exp Ther 331: 429-436, 2009.
15. Jiménez-Altayó F, Martín A, Rojas S, Justicia C, Briones AM, Giraldo J, Planas AM, Vila E. Transient middle cerebral artery occlusion causes different structural, mechanical, and myogenic alterations in normotensive and hypertensive rats. Am J Physiol Heart Circ Physiol 293: H628-H635, 2007.
16. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler Gobin YP G, Jahan R, Vespa P, Villablanca JP, Liebeskind DS, Woods RP, Alger JR. Diffusion-perfusion MRI characterization of post recanalization hyperperfusion in humans. Neurology 57: 2015-2021, 2001.
17. Kim KM, Henderson GN, Ouyang X, Frye RF, Sautin YY, Feig DI, Johnson RJ. A sensitive and specific liquid chromatography-tandem mass spectrometry method for the determination of intracellular and extracellular uric acid. J Chromatogr B Analyt Technol Biomed Life Sci 877: 2032-2038, 2009.
18. Ma YH, Su N, Chao XD, Zhang YQ, Zhang L, Han Luo P F, Fei Z, Qu Y. Thioredoxin-1 attenuates post-ischemic neuronal apoptosis via reducing oxidative/nitrative stress. Neurochem Int 60: 475-483, 2012.
19. Maneen MJ, Hannah R, Vitullo L, DeLance N, Cipolla MJ. Peroxynitrite diminishes myogenic activity and is associated with decreased vascular smooth muscle F-actin in rat posterior cerebral arteries. Stroke 37: 894-899, 2006.
20. Mellander S. Functional aspects of myogenic vascular control. J Hypertens Suppl 7: S21-S31, 1989.
21. Novensa L, Selent J, Pastor M, Sandberg K, Heras M, Dantas AP. Equine estrogens impair nitric oxide production and endothelial nitric oxide synthase transcription in human endothelial cells compared with the natural 17β-estradiol. Hypertension 56: 405-411, 2010.
22. Palomares SM, Cipolla MJ. Myogenic tone as a therapeutic target for ischemic stroke. Curr Vasc Pharmacol 12: 788-800, 2014.
23. Pérez-Asensio FJ, de la Rosa X, Jiménez-Altayó F, Gorina R, Martínez E, Messeguer A, Vila E, Chamorro A, Planas AM. Antioxidant CR-6 protects against reperfusion injury after a transient episode of focal brain ischemia in rats. J Cereb Blood Flow Metab 30: 638-652, 2010.
24. Pires PW, Dams Ramos CM, Matin N, Dorrance AM. The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol 304: H1598-H1614, 2013.
25. Pires PW, Girgla SS, McClain JL, Kaminski NE, van Rooijen N, Dorrance AM. Improvement in middle cerebral artery structure and endothelial function in stroke-prone spontaneously hypertensive rats after macrophage depletion. Microcirculation 20: 650-661, 2013.
26. Pires PW, Girgla SS, Moreno G, McClain JL, Dorrance AM. Tumor necrosis factor- inhibition attenuates middle cerebral artery remodeling but increases cerebral ischemic damage in hypertensive rats. Am J Physiol Heart Circ Physiol 307: H658-H669, 2014.
27. Planas AM, Traystman RJ. Advances in translational medicine 2010. Stroke 42: 283-284, 2011.
28. Romanos E, Planas AM, Amaro S, Chamorro A. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab 27: 14-20, 2007.
29. Shi H, Liu KJ. Cerebral tissue oxygenation and oxidative brain injury during ischemia and reperfusion. Front Biosci 12: 1318-1328, 2007.
30. Skinner KA, White CR, Patel R, Tan S, Barnes S, Kirk M, Darley- Usmar V, Parks DA. Nitrosation of uric acid by peroxynitrite. Formation of a vasoactive nitric oxide donor. J Biol Chem 273: 24491-24497, 1998.
31. Stenmark KR, Yeager ME, El Kasmi KC, Nozik-Grayck E, Gerasimovskaya EV, Li M, Riddle SR, Frid MG. The adventitia: essential regulator of vascular wall structure and function. Annu Rev Physiol 75: 23-47, 2013.
32. Stoll G, Jander S, Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56: 149-171, 1998.
33. Tamura A, Asano T, Sano K. Correlation between rCBF and histological changes following temporary middle cerebral artery occlusion. Stroke 11: 487-493, 1980.
34. Traupe H, Kruse E, Heiss WD. Reperfusion of focal ischemia of varying duration: postischemic hyper- and hypo-perfusion. Stroke 13: 615-622, 1982.
35. Tsuchidate R, He QP, Smith ML, Siesjö BK. Regional cerebral blood flow during and after 2 h of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 17: 1066-1073, 1997.
36. Vessières E, Freidja ML, Loufrani L, Fassot C, Henrion D. Flow (shear stress)-mediated remodeling of resistance arteries in diabetes. Vascul Pharmacol 57: 173-178, 2012.
37. Walsh JG, Muruve DA, Power C. Inflammasomes in the CNS. Nat Rev Neurosci 15: 84-97, 2014.
38. Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, Lo EH. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke 35, Suppl 1: 2726-2730, 2004.
39. Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 53: 613-625, 1998.